These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19896761)

  • 1. Implementation of guidelines on oxytocin use at caesarean section: a survey of practice in Great Britain and Ireland.
    Sheehan SR; Wedisinghe L; Macleod M; Murphy DJ
    Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):121-4. PubMed ID: 19896761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oxytocin to prevent haemorrhage at caesarean section--a survey of practice in the United Kingdom.
    Wedisinghe L; Macleod M; Murphy DJ
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):27-30. PubMed ID: 17544563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol. ECSSIT - Elective Caesarean Section Syntocinon Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section.
    Murphy DJ; Carey M; Montgomery AA; Sheehan SR;
    BMC Pregnancy Childbirth; 2009 Aug; 9():36. PubMed ID: 19703279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Australian and New Zealand survey of practice of the use of oxytocin at elective caesarean section.
    Mockler JC; Murphy DJ; Wallace EM
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):30-5. PubMed ID: 20218994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of anaesthetists on uterotonic usage practices for elective caesarean section in Australia and New Zealand.
    Terblanche NC; Otahal P; Sharman JE
    Anaesth Intensive Care; 2021 Nov; 49(6):440-447. PubMed ID: 34657486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of dose-finding studies on administration of oxytocin during caesarean section in the UK.
    West R; West S; Simons R; McGlennan A
    Anaesthesia; 2013 Oct; 68(10):1021-5. PubMed ID: 23944710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intrauterine misoprostol on blood loss during caesarean section.
    Bahadur A; Khoiwal K; Bhattacharya N; Chaturvedi J; Kumari R
    J Obstet Gynaecol; 2019 Aug; 39(6):753-756. PubMed ID: 31010345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial.
    Sheehan SR; Montgomery AA; Carey M; McAuliffe FM; Eogan M; Gleeson R; Geary M; Murphy DJ;
    BMJ; 2011 Aug; 343():d4661. PubMed ID: 21807773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of recurrent genital herpes infection in pregnancy: a postal survey of obstetric practice.
    Brocklehurst P; Carney O; Ross E; Mindel A
    Br J Obstet Gynaecol; 1995 Oct; 102(10):791-7. PubMed ID: 7547735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial.
    Güngördük K; Asicioglu O; Celikkol O; Olgac Y; Ark C
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):36-9. PubMed ID: 20218995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of oxytocin dosing at caesarean section.
    Stephens LC; Bruessel T
    Anaesth Intensive Care; 2012 Mar; 40(2):247-52. PubMed ID: 22417018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External cephalic version at term: a survey of consultant obstetric practice in the United Kingdom and Republic of Ireland.
    Coltart T; Edmonds DK; al-Mufti R
    Br J Obstet Gynaecol; 1997 May; 104(5):544-7. PubMed ID: 9166194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the benefits and hemodynamic side effects of oxytocin between intravenous infusion with and without bolus injection during caesarean section.
    Miyoshi Y; Kaneko S; Suga S; Koga M; Sugimi S; Yamashita H; Yamaguchi M; Yasuhi I
    J Obstet Gynaecol; 2021 May; 41(4):557-561. PubMed ID: 32729350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin use during Caesarean sections in Denmark - are we getting the dose right?
    Kjaer BN; Krøigaard M; Garvey LH
    Acta Anaesthesiol Scand; 2016 Jan; 60(1):18-25. PubMed ID: 26338081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ED
    Qian XW; Drzymalski DM; Lv CC; Guo FH; Wang LY; Chen XZ
    BMC Pregnancy Childbirth; 2019 Dec; 20(1):6. PubMed ID: 31892352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
    Dyer RA; Butwick AJ; Carvalho B
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood loss after caesarean section: depending on the management of oxytocin application?
    Pursche T; Diedrich K; Banz-Jansen C
    Arch Gynecol Obstet; 2012 Sep; 286(3):633-6. PubMed ID: 22569708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women.
    Hinshaw K; Simpson S; Cummings S; Hildreth A; Thornton J
    BJOG; 2008 Sep; 115(10):1289-95; discussion 1295-6. PubMed ID: 18715415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood loss and blood transfusion at caesarean section: a prospective observational study covering 30 years.
    Pearson GA; MacKenzie IZ
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():72-7. PubMed ID: 25145760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study to investigate the possible relationship between excess blood loss at caesarean section and reduced intra-operative oxytocin dose.
    Pearson GA; Pepper W; Russell R; MacKenzie IZ
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():31-7. PubMed ID: 26656199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.